CN Patent

CN102428098B — {[(2s，5r，8s，11s)-5-苄基-11-(3-胍基-丙基)-8-异丙基-7-甲基-3，6，9，12，15-五氧代-1，4，7，10，13-五氮杂-环十五烷-2-基]-乙酸}的新固体物质和获得它们的方法

Assigned to Merck Patent GmbH · Expires 2014-11-05 · 12y expired

What this patent protects

本发明涉及{[(2S，5R，8S，11S)-5-苄基-11-(3-胍基-丙基)-8-异丙基-7-甲基-3，6，9，12，15-五氧代-1，4，7，10，13-五氮杂-环十五烷-2-基]-乙酸}的新固体物质、制备它们的方法以及所述的固体物质在药物中的用途。

USPTO Abstract

本发明涉及{[(2S，5R，8S，11S)-5-苄基-11-(3-胍基-丙基)-8-异丙基-7-甲基-3，6，9，12，15-五氧代-1，4，7，10，13-五氮杂-环十五烷-2-基]-乙酸}的新固体物质、制备它们的方法以及所述的固体物质在药物中的用途。

Drugs covered by this patent

eltrombopag-choline (ELTROMBOPAG CHOLINE)

Patent Metadata

Patent number: CN102428098B
Jurisdiction: CN
Classification: —
Expires: 2014-11-05
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.